Xbird is a medical artificial intelligence (AI) company using advanced technology and
employing the latest know-how in data science and machine learning to improve
diabetes therapy. Xbird uses smartphones and wearables to automatically detect
adverse health events for diabetes patients. Their Continuous Activity Monitoring
creates a patient day journey, highlighting the activities that happened in the context of
hypoglycemic events. All of this happens automatically, without the need for any manual
logging from the user. This enables patients and health care practitioners to better
understand the context around adverse events and improve therapy.
Lipotype is a spin-off company of the Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden, Germany. The company has developed a lipidomics technology that can be employed for lipid identification and absolute quantification in basic and clinical research, for the biotech, pharma, food and cosmetics industry, for routine clinical diagnostics and for personalized health care.
Ada Health is an innovative health technology company that believes everyone in the world should have access to quality, personalized health information and care. Developed by a team of doctors, scientists and engineers, Ada Health launched its conversational health companion app to empower people with personalized medical insights and identify appropriate next steps. Supported by a sophisticated AI engine and curated medical knowledge base, Ada also augments doctors by providing earlier health information and decision support. Ada’s personal health companion app is available on iOS and Android and has been one of the fastest growing medical apps in 2017, ranked #1 in over 130 countries.
SpinDiag addresses the challenge of patients introducing drug-resistant bacteria into hospitals. The company will provide the rapid point-of-care screening system, SpinDiag One, to test high-risk patients for all relevant drug-resistances to allow hospital staff to decide on the spot whether or not to isolate a patient.
Caresyntax is based in the healthcare hub of Boston, is a technology enabled service provider focused on improving surgical patient outcome by improving efficiency of real-time intra-operative activities of clinicians and by providing rich retrospective analytics of surgical team performance.
Hepa Wash has developed an extracorporeal multiple-organ support therapy. The ADVOS treatment (Advanced Organ Support) is a dialysis procedure that is able to remove both water-soluble as well as protein-bound toxins. This procedure supports the detoxification of the liver, lungs and kidneys. The procedure is CE marked and already in clinical application.
labfolder builds a well-designed productivity platform for research teams, supporting scientists in their quest to make groundbreaking discoveries.
For scientific research teams which have always documented their invaluable research on paper, and which would like to manage their increasingly large and complex research data sets more efficiently, labfolder is a productivity & collaboration platform for the lab, that makes it easier to record findings and make new discoveries. Unlike the traditional paper lab notebook, labfolder makes it easy to create, find, share, discuss & validate research data as a team.
labfolder is used by more than 15,000 international scientists in all disciplines. It is used by academic as well as industrial and pharmaceutical scientists in R&D, analysis, and production labs. The cloud service is free for teams up to three users, for more team members and advanced features different pricing plans for academia and enterprise labs are available at www.labfolder.com/pricing
labfolder was founded in 2013 by molecular biologist Simon Bungers (CEO) and biophysicist Florian Hauer (COO), who were later joined by Yannick Skop (CCO) and Mario Russo (CTO).
Protembis is a medical device startup company headquartered in the engineering and technology city of Aachen, Germany. The company’s vision is to bring the ProtEmbo® System into every interventional heart procedure to minimize the risk of embolic cerebral lesions and to prevent substantial neurologic injury, thereby radically improving patient safety. Protembis is sponsored by the Federal Ministry of Education and Research as well as by a consortium of experienced private and institutional investors.
Scopis® GmbH (based in Berlin, Germany) develops and manufactures surgical planning and navigation systems for ENT, maxillofacial, neuro and spine surgery.
Scopis Target Guide Surgery (TGS®) is a unique “next-generation” solution for navigated endoscopic surgery that offers surgeons highly advanced image guidance and visualization capabilities using Augmented Reality. Scopis TGS® is provided by the Scopis Hybrid Navigation® system that is the first clinical navigation platform that offers electromagnetic, optical and simultaneous hybrid tracking technology in a single integrated control unit.
Scopis is the leader in medical Augmented Reality (AR). As only company worldwide Scopis offers the Augmented Reality for endoscopic and microscopic procedures.
Scopis operates in over 50 countries and has installed over 300 systems in operation theaters worldwide.